← FDA DRUG APPROVALS

FDA ANDA · ANDA040784

ACETAZOLAMIDE

Sponsor: XGEN PHARMS

APPLICATION
ANDA040784
TYPE
ANDA
ORIGINAL APPROVAL
2008-12-10
LATEST ACTION
2008-12-10
ROUTE
INTRAVENOUS, INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Prescription

Products

ACETAZOLAMIDE SODIUMPrescription
ACETAZOLAMIDE SODIUM EQ 500MG BASE/VIAL · INJECTABLE · INJECTION

Approval history

2008-12-10OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →